Volume 87 Issue 20 | pp. 24-26
Issue Date: May 18, 2009

Drug Firms Face Down Economy

Economic repercussions took a toll on first-quarter sales and earnings
Department: Business | Collection: Economy
Roche's buyout of Genentech takes a leading biotech firm off the earnings list.
Credit: Roche

THE GLOBAL financial decline that started in late 2008 slid even further during the first quarter of 2009. Most drug companies already had cost-cutting programs . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society